Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer.
Achinger-Kawecka J, Valdes-Mora F, Luu PL, Giles KA, Caldon CE, Qu W, Nair S, Soto S, Locke WJ, Yeo-Teh NS, Gould CM, Du Q, Smith GC, Ramos IR, Fernandez KF, Hoon DS, Gee JMW, Stirzaker C, Clark SJ.
Achinger-Kawecka J, et al. Among authors: locke wj.
Nat Commun. 2020 Jan 16;11(1):320. doi: 10.1038/s41467-019-14098-x.
Nat Commun. 2020.
PMID: 31949157
Free PMC article.